{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T07:52:53Z","timestamp":1691394773544},"reference-count":97,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.intimp.2008.03.020","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T16:35:55Z","timestamp":1209486955000},"page":"1344-1353","source":"Crossref","is-referenced-by-count":13,"title":["Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections"],"prefix":"10.1016","volume":"8","author":[{"given":"Amelia","family":"Ribeiro de Jesus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e2nia","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roque","family":"Pacheco de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Roberto Lima","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.intimp.2008.03.020_bib1","doi-asserted-by":"crossref","first-page":"I32","DOI":"10.1136\/ard.58.2008.i32","article-title":"The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease","volume":"58","author":"Kollias","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib2","first-page":"SR41","article-title":"Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered","volume":"9","author":"Martin","year":"2003","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.intimp.2008.03.020_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1084\/jem.193.4.427","article-title":"Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination","volume":"193","author":"Kassiotis","year":"2001","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.intimp.2008.03.020_bib4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrose factor: biology and therapeutic inhibitors","volume":"119","author":"Konstantinos","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2008.03.020_bib5","first-page":"446","article-title":"Tumour necrosis factor receptor distribution in human lymphoid tissue","volume":"74","author":"Ryffel","year":"1991","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.intimp.2008.03.020_bib6","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0002-9270(01)02494-7","article-title":"Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives","volume":"96","author":"Blam","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/01652176.2000.9695016","article-title":"Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review","volume":"22","author":"Witkamp","year":"2000","journal-title":"Vet Q"},{"key":"10.1016\/j.intimp.2008.03.020_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2310\/6650.2007.06013","article-title":"Plasma cytokines, metabolic syndrome, and atherosclerosis in humans","volume":"55","author":"Reilly","year":"2007","journal-title":"J Investig Med"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0151-9638(06)70873-0","article-title":"[TNF alpha in the physiopathology of psoriasis]","volume":"133","author":"Rozieres","year":"2006","journal-title":"Ann Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.intimp.2008.03.020_bib11","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8488","key":"10.1016\/j.intimp.2008.03.020_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1615\/JLongTermEffMedImplants.v13.i2.70","article-title":"Global epidemic of human T-cell lymphotrophic virus type-I (HTLV-I): an update","volume":"13","author":"Edlich","year":"2003","journal-title":"J. Long-term Eff. Med. Implants"},{"issue":"25","key":"10.1016\/j.intimp.2008.03.020_bib14","doi-asserted-by":"crossref","first-page":"14559","DOI":"10.1073\/pnas.251540598","article-title":"IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM\/TSP patients","volume":"98","author":"Azimi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2008.03.020_bib15","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1086\/344269","article-title":"Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease","volume":"186","author":"Jacobson","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/317932","article-title":"Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11\u201319-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis: correlation with HTLV-I provirus load","volume":"183","author":"Nagai","year":"2001","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J Neurovirol"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2249.2006.03150.x","article-title":"Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)\/tropical spastic paraparesis (HAM\/TSP) disease from HTLV-1 carrier state","volume":"145","author":"Guerreiro","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/13550280390194028","article-title":"Human T-cell lymphotropic virus type I and neurological diseases","volume":"9","author":"Nagai","year":"2003","journal-title":"J Neurovirol"},{"issue":"4","key":"10.1016\/j.intimp.2008.03.020_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers","volume":"2","author":"Santos","year":"2004","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jnr.490280213","article-title":"T-lymphocyte entry into the central nervous system","volume":"28","author":"Hickey","year":"1991","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2008.03.020_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2004.10.011","article-title":"CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha","volume":"159","author":"Narikawa","year":"2005","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.intimp.2008.03.020_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000097259","article-title":"Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1","volume":"13","author":"Santos","year":"2006","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13550280260422668","article-title":"Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP)","volume":"8","author":"Osame","year":"2002","journal-title":"J Neurovirol"},{"key":"10.1016\/j.intimp.2008.03.020_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1590\/S1677-55382007000200016","article-title":"Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals","volume":"33","author":"Castro","year":"2007","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.intimp.2008.03.020_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.urology.2007.01.052","article-title":"Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers","volume":"69","author":"Castro","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.intimp.2008.03.020_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(94)00266-Q","article-title":"Progression of neurological disability in HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"129","author":"Ara\u00fajo","year":"1995","journal-title":"Neurol Sci"},{"key":"10.1016\/j.intimp.2008.03.020_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0404.1993.tb04188.x","article-title":"Clinical and demographic features of HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Rio de Janeiro, Brazil","volume":"88","author":"Araujo A de","year":"1993","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4269\/ajtmh.1996.54.178","article-title":"Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB\/C mice","volume":"54","author":"Almeida","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/00034989760716","article-title":"Genetic diversity among Leishmania (Viannia) parasites","volume":"91","author":"Cupolillo","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/IAI.72.1.508-514.2004","article-title":"Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis","volume":"72","author":"Schriefer","year":"2004","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.intimp.2008.03.020_bib33","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","article-title":"Up-regulation of Th1-type responses in mucosal leishmaniasis patients","volume":"70","author":"Bacellar","year":"2002","journal-title":"Infect Immun"},{"issue":"1359","key":"10.1016\/j.intimp.2008.03.020_bib34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1098\/rstb.1997.0118","article-title":"Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study","volume":"352","author":"Blackwell","year":"1997","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib35","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.182.5.1259","article-title":"Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis","volume":"182","author":"Cabrera","year":"1995","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.intimp.2008.03.020_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/505504","article-title":"IL6-174 G\/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil","volume":"194","author":"Castellucci","year":"2006","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.intimp.2008.03.020_bib37","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1086\/340261","article-title":"Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection","volume":"34","author":"Follador","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.intimp.2008.03.020_bib38","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/IAI.70.12.6919-6925.2002","article-title":"Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection","volume":"70","author":"Karplus","year":"2002","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.intimp.2008.03.020_bib39","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1086\/345772","article-title":"Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil","volume":"186","author":"Turetz","year":"2002","journal-title":"J Infect Dis"},{"issue":"4845","key":"10.1016\/j.intimp.2008.03.020_bib40","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.3344436","article-title":"Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity","volume":"239","author":"Titus","year":"1988","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.intimp.2008.03.020_bib41","first-page":"267","article-title":"Human leishmaniases: epidemiology and public health aspects","volume":"45","author":"Desjeux","year":"1992","journal-title":"World Health Stat Q"},{"issue":"3","key":"10.1016\/j.intimp.2008.03.020_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib43","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0035-9203(83)90185-2","article-title":"The American leishmaniases: some observations on their ecology and epidemiology","volume":"77","author":"Lainson","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/infdis\/156.1.73","article-title":"Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis","volume":"156","author":"Jones","year":"1987","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.intimp.2008.03.020_bib45","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1086\/498042","article-title":"The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis","volume":"192","author":"Ben Salah","year":"2005","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/S0037-86821999000500005","article-title":"[Outbreak of American cutaneous leishmaniasis in Canoa, Santo Amaro, Bahia, Brazil]","volume":"32","author":"Follador","year":"1999","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.intimp.2008.03.020_bib47","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.135.6.4144","article-title":"Cell mediated immunity in American cutaneous and mucosal leishmaniasis","volume":"135","author":"Carvalho","year":"1985","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib48","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.135.6.4144","article-title":"Cell mediated immunity in American cutaneous and mucosal leishmaniasis","volume":"135","author":"Carvalho","year":"1985","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0100-879X1998000100020","article-title":"Cytokine profile and pathology in human leishmaniasis","volume":"31","author":"Ribeiro-de-Jesus","year":"1998","journal-title":"Braz J Med Biol Res"},{"issue":"11","key":"10.1016\/j.intimp.2008.03.020_bib50","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2008.03.020_bib51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-065X.1992.tb01414.x","article-title":"Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection","volume":"127","author":"Sher","year":"1992","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/expr.1996.0104","article-title":"Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis","volume":"84","author":"Bomfim","year":"1996","journal-title":"Exp Parasitol"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib53","first-page":"42","article-title":"[Immunopathology of American tegumentary leishmaniasis]","volume":"49","author":"Castes","year":"1998","journal-title":"Acta Cient Venez"},{"issue":"12","key":"10.1016\/j.intimp.2008.03.020_bib54","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1086\/340526","article-title":"Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer","volume":"34","author":"Machado","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.intimp.2008.03.020_bib55","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1128\/IAI.73.12.7853-7859.2005","article-title":"Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis","volume":"73","author":"Faria","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/S0074-02761991000100009","article-title":"Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis","volume":"86","author":"Bittencourt","year":"1991","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib57","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2249.2004.02426.x","article-title":"Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation","volume":"136","author":"Antonelli","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2008.03.020_bib58","article-title":"Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis","volume":"2","author":"Antonelli","year":"2005","journal-title":"Immunol Lett"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib59","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1086\/315082","article-title":"Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous leishmaniasis","volume":"180","author":"Almeida","year":"1999","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2005.73.79","article-title":"Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials","volume":"73","author":"Almeida","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.intimp.2008.03.020_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"Lessa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib62","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib63","first-page":"449","article-title":"Evidence of in situ cytotoxicity in American cutaneous leishmaniasis","volume":"12","author":"Machado","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.intimp.2008.03.020_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-3024.2007.00940.x","article-title":"Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis","volume":"29","author":"Carvalho","year":"2007","journal-title":"Parasite Immunol"},{"issue":"10","key":"10.1016\/j.intimp.2008.03.020_bib65","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0167-5699(97)01118-3","article-title":"Taming TNF: strategies to restrain this proinflammatory cytokine","volume":"18","author":"Eigler","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.intimp.2008.03.020_bib66","first-page":"240","article-title":"Production and regulation of tumor necrosis factor alpha. A cellular and molecular analysis","volume":"13","author":"Kunkel","year":"1988","journal-title":"Methods Achiev Exp Pathol"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib67","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/gast.2002.33426","article-title":"Biologic therapy of inflammatory bowel disease","volume":"122","author":"Sandborn","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2008.03.020_bib68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.1997.00435.x","article-title":"Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes","volume":"90","author":"Neuner","year":"1997","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib69","first-page":"230","article-title":"[New properties of trental as an inhibitor of viral activity with a wide range of activity]","volume":"38","author":"Amvros'eva","year":"1993","journal-title":"Voprosy virusologii"},{"issue":"7","key":"10.1016\/j.intimp.2008.03.020_bib70","first-page":"778","article-title":"Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action","volume":"6","author":"Biswas","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib71","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1128\/JVI.72.6.4712-4720.1998","article-title":"Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT","volume":"72","author":"Navarro","year":"1998","journal-title":"J Virol."},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib72","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00002030-199605000-00004","article-title":"Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation","volume":"10","author":"Navarro","year":"1996","journal-title":"Aids"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib73","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/593570","article-title":"Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons","volume":"175","author":"Clerici","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.intimp.2008.03.020_bib74","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.V89.10.3682.3682_3682_3690","article-title":"Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro","volume":"89","author":"Staak","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib75","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00364972","article-title":"Respiratory distress syndrome in patients with advanced cancer treated with pentoxifylline: a randomized study","volume":"1","author":"Ardizzoia","year":"1993","journal-title":"Support. Care Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2008.03.020_bib76","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2169\/internalmedicine.38.717","article-title":"Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy","volume":"38","author":"Fujimoto","year":"1999","journal-title":"Intern Med (Tokyo, Japan)"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib77","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-510X(97)00074-9","article-title":"Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy","volume":"151","author":"Shirabe","year":"1997","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.intimp.2008.03.020_bib78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-4362.2003.01868.x","article-title":"American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline","volume":"42","author":"Bafica","year":"2003","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.intimp.2008.03.020_bib79","doi-asserted-by":"crossref","first-page":"934","DOI":"10.7326\/0003-4819-113-12-934","article-title":"Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis","volume":"113","author":"Franke","year":"1990","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.intimp.2008.03.020_bib80","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-4632.2006.02867.x","article-title":"Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis","volume":"45","author":"Sadeghian","year":"2006","journal-title":"Int J Dermatol"},{"issue":"8452","key":"10.1016\/j.intimp.2008.03.020_bib81","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1568-9972(03)00048-X","article-title":"The biology of TNF blockade","volume":"2","author":"Suryaprasad","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2008.03.020_bib83","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(01)00287-8","article-title":"The effect of antiretroviral therapy on HTLV infection","volume":"78","author":"Machuca","year":"2001","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.intimp.2008.03.020_bib84","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial","volume":"46","author":"Izumo","year":"1996","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.intimp.2008.03.020_bib85","first-page":"1225","article-title":"[Recent advances in the treatment the nervous system disorders with interferon-alpha]","volume":"29","author":"Cabrera-Gomez","year":"1999","journal-title":"Rev Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0404.1992.tb08059.x","article-title":"Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy","volume":"86","author":"Kuroda","year":"1992","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib87","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","article-title":"Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"2","author":"Nakagawa","year":"1996","journal-title":"J Neurovirol"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/380101","article-title":"Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"189","author":"Saito","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib89","first-page":"32","article-title":"[Potentially treatable subacute forms of infection due to the HTLV-1]","volume":"31","author":"Carod-Artal","year":"2000","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199001043220104","article-title":"Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma","volume":"322","author":"Badaro","year":"1990","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.intimp.2008.03.020_bib91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s004360050529","article-title":"The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasis","volume":"85","author":"Becker","year":"1999","journal-title":"Parasitol Res"},{"issue":"10","key":"10.1016\/j.intimp.2008.03.020_bib92","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1086\/424848","article-title":"Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study","volume":"190","author":"Santos","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.intimp.2008.03.020_bib93","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/162.1.224","article-title":"Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis","volume":"162","author":"Ho","year":"1990","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.intimp.2008.03.020_bib94","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.175.6.1717","article-title":"Novel responses of human skin to intradermal recombinant granulocyte\/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing","volume":"175","author":"Kaplan","year":"1992","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.intimp.2008.03.020_bib95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0002-9610(97)89589-X","article-title":"Double-blind randomized placebo-controlled trial of the use of granulocyte\u2013macrophage colony-stimulating factor in chronic leg ulcers","volume":"173","author":"Marques da Costa","year":"1997","journal-title":"Am J Surg"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2008.03.020_bib96","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1007\/BF01973601","article-title":"Effects of granulocyte-macrophage colony-stimulating factor on wound contraction","volume":"13","author":"Robson","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.intimp.2008.03.020_bib97","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1084\/jem.166.5.1436","article-title":"Recombinant human granulocyte\/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages","volume":"166","author":"Weiser","year":"1987","journal-title":"J Exp Med"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:16:51Z","timestamp":1684369011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576908001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":97,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1567576908001112"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2008.03.020","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}